258 related articles for article (PubMed ID: 9316304)
1. Recent progress in diagnosis and treatment of osteogenesis imperfecta.
Moriwake T; Seino Y
Acta Paediatr Jpn; 1997 Aug; 39(4):521-7. PubMed ID: 9316304
[TBL] [Abstract][Full Text] [Related]
2. Osteogenesis imperfecta: practical treatment guidelines.
Antoniazzi F; Mottes M; Fraschini P; Brunelli PC; Tatò L
Paediatr Drugs; 2000; 2(6):465-88. PubMed ID: 11127846
[TBL] [Abstract][Full Text] [Related]
3. Type V osteogenesis imperfecta: a new form of brittle bone disease.
Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
[TBL] [Abstract][Full Text] [Related]
4. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.
Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R
J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667
[TBL] [Abstract][Full Text] [Related]
5. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
6. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers.
Patel RM; Nagamani SC; Cuthbertson D; Campeau PM; Krischer JP; Shapiro JR; Steiner RD; Smith PA; Bober MB; Byers PH; Pepin M; Durigova M; Glorieux FH; Rauch F; Lee BH; Hart T; Sutton VR
Clin Genet; 2015 Feb; 87(2):133-40. PubMed ID: 24754836
[TBL] [Abstract][Full Text] [Related]
8. Update on the evaluation and treatment of osteogenesis imperfecta.
Harrington J; Sochett E; Howard A
Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022
[TBL] [Abstract][Full Text] [Related]
9. Modern approach to children with osteogenesis imperfecta.
Zeitlin L; Fassier F; Glorieux FH
J Pediatr Orthop B; 2003 Mar; 12(2):77-87. PubMed ID: 12584489
[TBL] [Abstract][Full Text] [Related]
10. Severe osteogenesis imperfecta Type-III and its challenging treatment in newborn and preschool children. A systematic review.
Sinikumpu JJ; Ojaniemi M; Lehenkari P; Serlo W
Injury; 2015 Aug; 46(8):1440-6. PubMed ID: 25943292
[TBL] [Abstract][Full Text] [Related]
11. Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations.
Fratzl-Zelman N; Schmidt I; Roschger P; Glorieux FH; Klaushofer K; Fratzl P; Rauch F; Wagermaier W
Bone; 2014 Mar; 60():122-8. PubMed ID: 24296239
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up in osteogenesis imperfecta type VI.
Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
[TBL] [Abstract][Full Text] [Related]
13. [Osteogenesis imperfecta].
Salzmann M; Krohn C; Berger N
Orthopade; 2014 Aug; 43(8):764-71. PubMed ID: 25116245
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.
Paschalis EP; Gamsjaeger S; Fratzl-Zelman N; Roschger P; Masic A; Brozek W; Hassler N; Glorieux FH; Rauch F; Klaushofer K; Fratzl P
J Bone Miner Res; 2016 May; 31(5):1050-9. PubMed ID: 26748579
[TBL] [Abstract][Full Text] [Related]
16. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.
Roschger P; Fratzl-Zelman N; Misof BM; Glorieux FH; Klaushofer K; Rauch F
Calcif Tissue Int; 2008 Apr; 82(4):263-70. PubMed ID: 18311573
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype relationship in a large cohort of osteogenesis imperfecta patients with COL1A1 mutations revealed by a new scoring system.
Li LJ; Lyu F; Song YW; Wang O; Jiang Y; Xia WB; Xing XP; Li M
Chin Med J (Engl); 2019 Jan; 132(2):145-153. PubMed ID: 30614853
[TBL] [Abstract][Full Text] [Related]
18. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease.
Ward LM; Rauch F; Travers R; Chabot G; Azouz EM; Lalic L; Roughley PJ; Glorieux FH
Bone; 2002 Jul; 31(1):12-8. PubMed ID: 12110406
[TBL] [Abstract][Full Text] [Related]
19. Orthopaedic and dental abnormalities in osteogenesis imperfecta: a review of the literature.
Scaramuzzo L; Raffaelli L; Spinelli MS; Damis G; Maccauro G; Manicone PF
J Biol Regul Homeost Agents; 2011; 25(3):313-21. PubMed ID: 22023755
[TBL] [Abstract][Full Text] [Related]
20. [Pathologic anatomy of osteogenesis imperfecta. Light and electron microscopic studies of supportive tissue and skin].
Stöss H
Veroff Pathol; 1990; 134():1-88. PubMed ID: 2385955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
